Botanical Profile
Dipsacus fullonum L. — Root (dried; primary medicinal part); Leaf (traditional); Seed head (ecological/craft use). Native to Europe, North Africa, and western Asia; widely naturalized across North America as a roadside and field biennial; now common throughout temperate North America
Root: bitter, slightly acrid, pungent; dense, fibrous cross-section with distinctive central channel in older roots; strong earthy-bitter aroma when cut fresh. Dried root: dark tan-brown, hard, fibrous. Taste: intensely bitter with earthy, woody undertones. The bitterness is characteristic and becomes important as a diagnostic indicator — authentic teasel root should be noticeably bitter. Water extracted from the leaf axis ('Venus' basin') was traditionally used as an eye wash and cosmetic.
Dipsacus fullonum (wild teasel) and Dipsacus sativus (Fuller's teasel, with hooked bracts) are closely related and used interchangeably medicinally. Both are naturalized in North America. Dipsacus asper (Asian teasel, Xu Duan in Chinese medicine) is a distinct species with a more extensively documented clinical record in Chinese herbal medicine, but D. fullonum shares key active compounds and is the primary Western species.
Active Compound Profile
Tincture or decoction for iridoid glycoside extraction: Iridoid glycosides are water-soluble and ethanol-soluble; both decoction and tincture preparations effectively extract key active compounds; tincture provides greater consistency and shelf stability
Mechanism of Action
What It Moves in Your Labs
| Biomarker | Direction | Target | Mechanism |
|---|---|---|---|
| hs-CRP | ↓ Decrease | <1.0 mg/L | Iridoid glycoside NF-κB inhibition reduces systemic inflammatory cytokine production |
| Liver Enzymes (ALT, AST) | ↓ Decrease (if elevated) | ALT <35 IU/L; AST <35 IU/L | Hepatoprotective iridoids protect hepatocytes from inflammatory and oxidative damage; relevant if concurrent liver stress from medications or infections |
| Bone Density (DEXA) | ↑ Improve | T-score > -1.0 (within normal range) | Dipsacus saponin stimulation of osteoblastogenesis via Wnt/β-catenin; RANKL inhibition of osteoclast differentiation |
| Joint Pain (VAS or WOMAC) | ↓ Decrease | Clinical improvement in joint pain scores | NF-κB-mediated reduction of synovial inflammation; prostaglandin pathway modulation by iridoids |
Extraction & Preparation
Tincture (1:5, 60% ethanol): Full iridoid glycoside extraction; saponins and polyphenols included
Dosing Framework
Anti-inflammatory/Lyme protocol: take 3 doses spread throughout the day; with meals to reduce any GI discomfort from bitter compounds; morning, midday, evening timing.
Synergy Partners
THE LYME-HASHIMOTO OVERLAP PROTOCOL
Components: Teasel Root (Dipsacus fullonum) + Japanese Knotweed (Polygonum cuspidatum) + Cat's Claw (Uncaria tomentosa) + Astragalus (Astragalus membranaceus) · Multi-pathway convergence: Anti-spirochetal / antimicrobial (teasel + knotweed + cat's claw) + NF-κB inhibition (knotweed resveratrol + teasel iridoids) + immune normalization (cat's claw + astragalus) + HPA adaptogenic support (astragalus) · Borrelia burgdorferi infection is documented as a significant trigger and perpetuator of autoimmune thyroid disease, including Hashimoto's. This stack addresses the Lyme-Hashimoto overlap that is clinically common but rarely recognized in conventional medicine. The herbs address both the potential microbial trigger and the resulting autoimmune inflammatory response. · Practical integration: Joint Support Tincture Blend (teasel + knotweed + cat's claw) taken 3x daily; astragalus decoction or tincture separately in morning protocol; work with a Lyme-literate integrative practitioner to determine if Lyme testing and protocol is indicated.
Contraindications & Interactions
Evidence Base
Evidence Gaps
The highest-value research gap for Meridian Medica: no human RCT has evaluated teasel root specifically for Hashimoto's thyroiditis or Lyme-associated autoimmune thyroid disease. A controlled pilot study evaluating teasel root tincture in Hashimoto's patients with confirmed or suspected Borrelia co-infection (measuring TPO antibodies, inflammatory markers, and Borrelia serology) would be a unique contribution to both integrative Lyme medicine and autoimmune thyroid disease management. Additionally, direct in vitro anti-Borrelia testing of D. fullonum specifically (rather than generic antimicrobial claims) would strengthen or refute the Buhner protocol scientific basis.
Teasel root adulteration risk has increased with the Lyme disease herbal protocol market:
Protocol Integration
Layer 1: Hypothalamic / Autonomic — HPA axis, circadian rhythm, stress response
Layer 2: Systemic Nutritional Repletion — Micronutrient optimization, antioxidant defense
Layer 3: Gut Permeability / Microbiome — Tight junction repair, motility, SIBO management
Teasel Root appears in the following Meridian Medica protocol contexts: